Aishwarya Subramanian, PhD
About Aishwarya Subramanian, PhD
Aishwarya Subramanian, PhD, is a Biomedical Data Analyst at BenchSci in Toronto, Canada, with extensive experience in molecular oncology and cancer research. She holds a PhD from the Center for Genomic Science and has been actively involved in science communication and career development activities.
Work at BenchSci
Aishwarya Subramanian has been employed as a Biomedical Data Analyst at BenchSci since 2020. In this role, she contributes to the analysis of biomedical data, focusing on enhancing the efficiency of scientific research. BenchSci is known for its innovative approach to data analysis in the life sciences sector, and Subramanian's expertise supports the company's mission to accelerate drug discovery.
Education and Expertise
Aishwarya Subramanian holds a Bachelor of Science (B.Sc.) in Biotechnology from the University of Madras, completed between 2006 and 2009. She furthered her education with a Master of Science (M.Sc.) in Biotechnology from SRM University, from 2009 to 2011. Subramanian earned her Doctor of Philosophy (PhD) in Molecular Oncology from the Center for Genomic Science, IIT@SEMM European School of Molecular Medicine, between 2012 and 2015. Her academic background provides a strong foundation for her work in biomedical data analysis and cancer research.
Background
Aishwarya Subramanian has a diverse professional background in biomedical research. She began her career as a PhD Student in Molecular Oncology at Istituto Italiano di Tecnologia, where she worked from 2012 to 2015. After completing her PhD, she served as a Research Fellow at the same institution for six months. Subramanian has also held a position as a Postdoctoral Researcher at The Hospital for Sick Children since 2016, where she has engaged in various research projects.
Achievements
Throughout her career, Aishwarya Subramanian has been actively involved in science communication and career development activities. She served as Chair of the Career Development Committee at The Hospital for Sick Children from 2018 to 2020. Additionally, she has led a large-scale collaborative project that involved a cross-disciplinary team, focusing on cancer biology. Her work in designing and implementing cell-based assays for cancer research further highlights her contributions to the field.